BIOMAT Database Logo BIOMAT Database Logo

[Mutagenic and carcinogenic potency of furocoumarins. Experimental basis for risk assessment]. 1981

O Schimmer

UI MeSH Term Description Entries
D009153 Mutagens Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. Clastogen,Clastogens,Genotoxin,Genotoxins,Mutagen
D011564 Furocoumarins Polycyclic compounds consisting of a furan ring fused with coumarin. They commonly occur in PLANTS, especially UMBELLIFERAE and RUTACEAE, as well as PSORALEA. Furanocoumarin,Furanocoumarins,Furocoumarin,Psoralens,Angelicins
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012306 Risk The probability that an event will occur. It encompasses a variety of measures of the probability of a generally unfavorable outcome. Relative Risk,Relative Risks,Risk, Relative,Risks,Risks, Relative

Related Publications

O Schimmer
Carcinogenic potency and risk assessment.
January 1984, Food additives and contaminants,
O Schimmer
Mutagenic and carcinogenic potency indices and their correlation.
January 1990, Teratogenesis, carcinogenesis, and mutagenesis,
O Schimmer
[Notion of threshold in mutagenesis: implications for mutagenic and carcinogenic risk assessment].
November 2007, Annales pharmaceutiques francaises,
O Schimmer
Does carcinogenic potency correlate with mutagenic potency in the Ames assay?
July 1978, Nature,
O Schimmer
Does carcinogenic potency correlate with mutagenic potency in the Ames assay?
February 1978, Nature,
O Schimmer
The problem of the carcinogenic risk by furocoumarins.
January 1978, Progress in biochemical pharmacology,
O Schimmer
SOS chromotest results in a broader context: empirical relationships between genotoxic potency, mutagenic potency, and carcinogenic potency.
January 1996, Environmental and molecular mutagenesis,
O Schimmer
Legal implications of monitoring workers for carcinogenic and mutagenic risk.
January 1982, Teratogenesis, carcinogenesis, and mutagenesis,
O Schimmer
The structural basis of the carcinogenic and mutagenic potentials of phytoalexins.
September 1990, Mutation research,
O Schimmer
Carcinogenic effects of monofunctional and bifunctional furocoumarins.
December 1984, National Cancer Institute monograph,
Copied contents to your clipboard!